Source: The Real Deal

InterVenn: InterVenn scrubs lease for offices and labs in South SF

InterVenn Biosciences has torn up its 10-year-lease for a 142,000-square-foot building in South San Francisco. The biotech startup based in the city has canceled its lease for the office and research building at 499 Forbes Boulevard, the San Francisco Business Times reported. The lease was signed a year ago with San Francisco-based Aralon Properties. Terms [...]The post InterVenn scrubs lease for offices and labs in South SF appeared first on The Real Deal.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
Joshua Stahl's photo - CEO of InterVenn

CEO

Joshua Stahl

CEO Approval Rating

90/100

Read more